Trial intelligence / Profile preview

Phase 3 trial of a vaginal four-strain live Lactobacillus capsule to reduce recurrence of bacterial vaginosis

CTR20262257Phase 3Active

Sponsor
Anaerobio
Start
Jun 2026
Modality
Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Countries
1
01

Overview

A Phase 3 trial of vaginal four-strain live Lactobacillus capsule in bacterial vaginosis (BV), sponsored by Anaerobio. Started Jun 2026; status: active.

02

Drugs

vaginal four-strain live Lactobacillus capsule
03

Conditions

bacterial vaginosis (BV)

Beyond the preview

Go deeper on CTR20262257.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20262257.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call